Researcher.Life Logo

Pharmacological Reviews : Impact Factor & More

eISSN: 1521-0081pISSN: 0031-6997

Aims and Scope of Pharmacological Reviews

Pharmacological Reviews is a quarterly peer-reviewed scientific journal publishing review articles on all aspects of pharmacology and related topics. It is published by the American Society for Pharmacology and Experimental Therapeutics. The editor-in-chief is David R. Sibley (National Institute of Neurological Disorders and Stroke). Less

Key Metrics

CiteScore
35.4
Eigenfactor
0.005 - 0.01
Impact Factor
20 - 25
SJR
Q1Pharmacology
SNIP
6.44
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Pharmacological Reviews

Pharmacological Reviews Journal Specifications

Overview
Publisher AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year1949
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Pharmacological Reviews ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Pharmacological Reviews

Edaravone: Advances on cytoprotective effects, pharmacological properties, and mechanisms of action.
  • 1 Jan 2026
  • Pharmacological reviews
MiR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response.
  • 1 Jan 2026
  • Pharmacological reviews
Platelet activation, aspirin, and cancer: From basic science to clinical trials.
  • 1 Jan 2026
  • Pharmacological reviews
Modeling lung transporters and their influence on inhaled drug disposition.
  • 1 Jan 2026
  • Pharmacological reviews
Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment-A scoping review.
  • 1 Jan 2026
  • Pharmacological reviews
Computational drug design in the artificial intelligence era: A systematic review of molecular representations, generative architectures, and performance assessment.
  • 1 Jan 2026
  • Pharmacological reviews
Edaravone: Advances on cytoprotective effects, pharmacological properties, and mechanisms of action.
  • 1 Jan 2026
  • Pharmacological reviews
MiR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response.
  • 1 Jan 2026
  • Pharmacological reviews
Platelet activation, aspirin, and cancer: From basic science to clinical trials.
  • 1 Jan 2026
  • Pharmacological reviews
Modeling lung transporters and their influence on inhaled drug disposition.
  • 1 Jan 2026
  • Pharmacological reviews
Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment-A scoping review.
  • 1 Jan 2026
  • Pharmacological reviews
Computational drug design in the artificial intelligence era: A systematic review of molecular representations, generative architectures, and performance assessment.
  • 1 Jan 2026
  • Pharmacological reviews

FAQs on Pharmacological Reviews